Steris Plc (NYSE:STE) announced a quarterly dividend on Wednesday, November 1st, Zacks reports. Investors of record on Wednesday, November 22nd will be paid a dividend of 0.31 per share by the medical equipment provider on Wednesday, December 20th. This represents a $1.24 annualized dividend and a dividend yield of 1.42%. The ex-dividend date is Tuesday, November 21st.

Steris Plc has increased its dividend by an average of 9.8% annually over the last three years and has raised its dividend every year for the last 7 years. Steris Plc has a payout ratio of 30.5% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Steris Plc to earn $4.54 per share next year, which means the company should continue to be able to cover its $1.24 annual dividend with an expected future payout ratio of 27.3%.

Shares of Steris Plc (NYSE STE) opened at $87.61 on Thursday. The company has a current ratio of 2.80, a quick ratio of 2.18 and a debt-to-equity ratio of 0.48. Steris Plc has a 1 year low of $64.37 and a 1 year high of $93.39. The firm has a market capitalization of $7,506.72, a price-to-earnings ratio of 22.75 and a beta of 1.31.

Steris Plc (NYSE:STE) last issued its earnings results on Wednesday, November 1st. The medical equipment provider reported $0.94 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.95 by ($0.01). Steris Plc had a return on equity of 11.49% and a net margin of 5.59%. The firm had revenue of $634.20 million during the quarter, compared to analyst estimates of $629.02 million. During the same period in the previous year, the company earned $0.89 EPS. Steris Plc’s revenue for the quarter was down 1.9% on a year-over-year basis. analysts predict that Steris Plc will post 4.06 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This report was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another publication, it was stolen and republished in violation of United States & international copyright & trademark laws. The original version of this report can be viewed at

In other news, VP John Adam Zangerle sold 3,650 shares of the stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $88.00, for a total value of $321,200.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the stock in a transaction dated Wednesday, October 4th. The shares were sold at an average price of $90.50, for a total value of $905,000.00. The disclosure for this sale can be found here. In the last three months, insiders sold 192,722 shares of company stock valued at $16,913,753. Insiders own 2.55% of the company’s stock.

A number of equities analysts have issued reports on the company. TD Securities upped their target price on Steris Plc from C$14.00 to C$16.00 and gave the stock a “buy” rating in a report on Thursday, November 9th. Raymond James Financial, Inc. upped their target price on Steris Plc from $95.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday, October 16th. BidaskClub cut Steris Plc from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Zacks Investment Research cut Steris Plc from a “buy” rating to a “sell” rating in a report on Monday, November 6th. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $101.00 target price (up previously from $91.00) on shares of Steris Plc in a report on Thursday, November 2nd. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $77.80.

About Steris Plc

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Dividend History for Steris Plc (NYSE:STE)

Receive News & Stock Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related stocks with our FREE daily email newsletter.